Nkarta (NKTX) Stock Forecast, Price Target & Predictions
NKTX Stock Forecast
Nkarta stock forecast is as follows: an average price target of $21.60 (represents a 278.28% upside from NKTX’s last price of $5.71) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
NKTX Price Target
The average price target for Nkarta (NKTX) is $21.60 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $36.00 to $15.00. This represents a potential 278.28% upside from NKTX's last price of $5.71.
NKTX Analyst Ratings
According to 8 Wall Street analysts, Nkarta's rating consensus is 'Buy'. The analyst rating breakdown for NKTX stock is 1 'Strong Buy' (12.50%), 7 'Buy' (87.50%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Nkarta Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 26, 2024 | Bill Maughan | Canaccord Genuity | $16.00 | $9.61 | 66.58% | 180.21% |
| Mar 22, 2024 | Gil Blum | Needham | $15.00 | $12.98 | 15.56% | 162.70% |
| Mar 22, 2024 | Salim Syed | Mizuho Securities | $25.00 | $8.92 | 180.27% | 337.83% |
| Mar 22, 2024 | Laura Prendergast | Raymond James | $16.00 | $8.92 | 79.37% | 180.21% |
| Apr 26, 2022 | - | Raymond James | $32.00 | $18.72 | 70.94% | 460.42% |
| Apr 26, 2022 | - | H.C. Wainwright | $36.00 | $18.72 | 92.31% | 530.47% |
The latest Nkarta stock forecast, released on Mar 26, 2024 by Bill Maughan from Canaccord Genuity, set a price target of $16.00, which represents a 66.58% increase from the stock price at the time of the forecast ($9.61), and a 180.21% increase from NKTX last price ($5.71).
Nkarta Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 4 |
| Avg Price Target | - | - | $18.00 |
| Last Closing Price | $5.71 | $5.71 | $5.71 |
| Upside/Downside | -100.00% | -100.00% | 215.24% |
In the current month, the average price target of Nkarta stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nkarta's last price of $5.71. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 14, 2024 | Raymond James | Outperform | Strong Buy | Upgrade |
| Jun 28, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Mar 26, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Mar 22, 2024 | Barclays | Buy | Buy | Hold |
| Mar 22, 2024 | Raymond James | Strong Buy | Outperform | Downgrade |
| Oct 17, 2023 | Raymond James | - | Strong Buy | Upgrade |
| Mar 17, 2023 | Credit Suisse | Buy | Buy | Hold |
| Dec 22, 2022 | Oppenheimer | Outperform | Perform | Downgrade |
| Dec 05, 2022 | Oppenheimer | Outperform | Outperform | Hold |
| Jul 18, 2022 | SVB Leerink | - | Outperform | Initialise |
Nkarta's last stock rating was published by Raymond James on Aug 14, 2024. The company Upgrade its NKTX rating from "Outperform" to "Strong Buy".
Nkarta Financial Forecast
Nkarta Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| # Analysts | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
Nkarta's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. NKTX's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Nkarta EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
undefined analysts predict NKTX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Nkarta's previous annual EBITDA (undefined) of $NaN.
Nkarta Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - |
| Avg Forecast | $-29.64M | $-29.40M | $-28.91M | $-29.15M | $-27.61M | $-26.46M | $-34.67M |
| High Forecast | $-29.64M | $-29.40M | $-28.91M | $-29.15M | $-27.61M | $-25.03M | $-34.67M |
| Low Forecast | $-29.64M | $-29.40M | $-28.91M | $-29.15M | $-27.61M | $-27.17M | $-34.67M |
| Surprise % | - | - | - | - | - | - | - |
Nkarta's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NKTX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Nkarta SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - |
Nkarta's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to NKTX last annual SG&A of $NaN (undefined).
Nkarta EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - |
| Avg Forecast | $-0.40 | $-0.40 | $-0.39 | $-0.40 | $-0.38 | $-0.36 | $-0.47 |
| High Forecast | $-0.40 | $-0.40 | $-0.39 | $-0.40 | $-0.38 | $-0.34 | $-0.47 |
| Low Forecast | $-0.40 | $-0.40 | $-0.39 | $-0.40 | $-0.38 | $-0.37 | $-0.47 |
| Surprise % | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Nkarta's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NKTX previous annual EPS of $NaN (undefined).
Nkarta Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BCEL | Atreca | $0.09 | $4.00 | 4344.44% | Buy |
| KZR | Kezar Life Sciences | $0.57 | $17.50 | 2970.18% | Buy |
| IPSC | Century Therapeutics | $1.60 | $20.00 | 1150.00% | Buy |
| NGM | NGM Biopharmaceuticals | $1.54 | $16.50 | 971.43% | Buy |
| LYEL | Lyell Immunopharma | $1.23 | $9.50 | 672.36% | Hold |
| PASG | Passage Bio | $0.81 | $6.00 | 640.74% | Buy |
| NKTX | Nkarta | $5.71 | $21.60 | 278.28% | Buy |
| SANA | Sana Bio | $4.47 | $12.00 | 168.46% | Buy |
| MLYS | Mineralys Therapeutics | $11.76 | $30.00 | 155.10% | Buy |
| BDTX | Black Diamond Therapeutics | $6.19 | $14.75 | 138.29% | Buy |
| RVMD | Revolution Medicines, Inc. Warrant | $43.70 | $51.20 | 17.16% | Buy |
NKTX Forecast FAQ
Is Nkarta a good buy?
Yes, according to 8 Wall Street analysts, Nkarta (NKTX) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 7 'Buy' recommendations, accounting for 100.00% of NKTX's total ratings.
What is NKTX's price target?
Nkarta (NKTX) average price target is $21.6 with a range of $15 to $36, implying a 278.28% from its last price of $5.71. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Nkarta stock go up soon?
According to Wall Street analysts' prediction for NKTX stock, the company can go up by 278.28% (from the last price of $5.71 to the average price target of $21.6), up by 530.47% based on the highest stock price target, and up by 162.70% based on the lowest stock price target.
Can Nkarta stock reach $9?
NKTX's average twelve months analyst stock price target of $21.6 supports the claim that Nkarta can reach $9 in the near future.
What are Nkarta's analysts' financial forecasts?
Nkarta's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-88.744M (high $-87.314M, low $-89.459M), average SG&A $0 (high $0, low $0), and average EPS is $-1.207 (high $-1.188, low $-1.217). NKTX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-117M (high $-117M, low $-117M), average SG&A $0 (high $0, low $0), and average EPS is $-1.593 (high $-1.593, low $-1.593).